These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 2667189)
1. [Is the measurement of carcinoembryonic antigen still indicated in digestive cancers?]. Ollyo JB; Gonvers JJ; Bauerfeind P; Restellini A; Cilluffo T; Blum AL Ther Umsch; 1989 Jun; 46(6):384-8. PubMed ID: 2667189 [TBL] [Abstract][Full Text] [Related]
2. Carcinoembryonic antigen fraction in digestive cancer. Fong S; García Vega G; León V Neoplasma; 1985; 32(2):199-208. PubMed ID: 4000309 [TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis]. Lorenz M; Happ J; Hottenrott C; Maul FD; Baum RP; Hör G; Encke A Nuklearmedizin; 1986 Feb; 25(1):9-14. PubMed ID: 3459133 [TBL] [Abstract][Full Text] [Related]
4. [Diagnostic value of a new serum marker of human digestive cancer: the carbohydrate antigen 19.9; comparison with the carcinoembryonic antigen]. Olsson NO; Crimet-Montange D; Martin F Gastroenterol Clin Biol; 1985 Mar; 9(3):206-11. PubMed ID: 3859449 [TBL] [Abstract][Full Text] [Related]
5. [Evaluation of the measurement of serum carcinoembryonic antigen (CEA) levels using monoclonal antibody]. Yoneshima M; Sawabu N; Kidani H; Takemori Y; Toya D; Okai T; Hattori N; Ogino T; Mai M Gan No Rinsho; 1985 Aug; 31(10):1311-7. PubMed ID: 4057566 [TBL] [Abstract][Full Text] [Related]
6. [Usefulness of the determination of CA 19-9 in the follow-up of patients with gastroenteric neoplasms in comparison to CEA]. Pecchio F; Piantino P; Oliaro A; Rapellino M; Ricci E; Aimo G; Obert R Minerva Med; 1986 Nov; 77(42-43):1973-81. PubMed ID: 3464850 [TBL] [Abstract][Full Text] [Related]
7. Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer. Wichmann MW; Lau-Werner U; Müller C; Hornung HM; Stieber P; Schildberg FW; Anticancer Res; 2000; 20(6D):4953-5. PubMed ID: 11326645 [TBL] [Abstract][Full Text] [Related]
8. Use of the preoperative levels of CEA in patients with colorectal cancer. Marchena J; Acosta MA; Garcia-Anguiano F; Simpson H; Cruz F Hepatogastroenterology; 2003; 50(52):1017-20. PubMed ID: 12845969 [TBL] [Abstract][Full Text] [Related]
9. Are carcinoembryonic antigen levels of value in the curative management of colorectal cancer? Wanebo HJ Surgery; 1981 Mar; 89(3):290-5. PubMed ID: 7466616 [TBL] [Abstract][Full Text] [Related]
10. [Prognostic value of CEA in postoperative monitoring of colorectal cancers]. Cossu F; Fodde M; Ledda P; Pisano G; Rombi GP; Scintu F; Tuveri A Minerva Med; 1984 Oct; 75(40):2373-80. PubMed ID: 6504398 [TBL] [Abstract][Full Text] [Related]
11. Carcinoembryonic antigen: usefulness as a postsurgical method in the detection of recurrence in Dukes stages B2 and C colorectal cancers. Koch M; Washer G; Gaedke H; McPherson TA J Natl Cancer Inst; 1982 Oct; 69(4):813-5. PubMed ID: 6956758 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of CEA levels and positive cytology in peritoneal washings in patients with colorectal cancer. Kanellos I; Zacharakis E; Kanellos D; Pramateftakis MG; Betsis D Colorectal Dis; 2006 Jun; 8(5):436-40. PubMed ID: 16684089 [TBL] [Abstract][Full Text] [Related]
13. Serum tumor markers in colorectal cancer staging, grading, and follow-up. Plebani M; De Paoli M; Basso D; Roveroni G; Giacomini A; Galeotti F; Corsini A J Surg Oncol; 1996 Aug; 62(4):239-44. PubMed ID: 8691835 [TBL] [Abstract][Full Text] [Related]
14. [Antigens (CEA and CA 19-9) in diagnosis and prognosis colorectal cancer]. Grotowski M Pol Merkur Lekarski; 2002 Jan; 12(67):77-80. PubMed ID: 11957811 [TBL] [Abstract][Full Text] [Related]
15. [Prognostic importance of preoperative CEA in patients with colorectal cancer]. Turoldo A; Balani A; Scaramucci M; Babic F; Guidolin D; Liguori G Chir Ital; 2002; 54(4):469-76. PubMed ID: 12239755 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance of carcinoembryonic antigen (CEA) in patients with adenocarcinoma in colon and rectum. Lunde OC; Havig O Acta Chir Scand; 1982; 148(2):189-93. PubMed ID: 7148317 [TBL] [Abstract][Full Text] [Related]
17. Clinical significance of carcinoembryonic antigen in colorectal malignancy. Mazumdar A; Verma GR; Bose SM; Ganguly NK Trop Gastroenterol; 1999; 20(3):107-10. PubMed ID: 10695415 [TBL] [Abstract][Full Text] [Related]
18. Periodic measurement of serum carcinoembryonic antigen and carbohydrate antigen 15-3 levels as postoperative surveillance after breast cancer surgery. Nakamura T; Kimura T; Umehara Y; Suzuki K; Okamoto K; Okumura T; Morizumi S; Kawabata T Surg Today; 2005; 35(1):19-21. PubMed ID: 15622458 [TBL] [Abstract][Full Text] [Related]
19. EIA versus RIA in detecting carcinoembryonic antigen level of patients with metastatic colorectal cancer. Wang WS; Lin JK; Lin TC; Chiou TJ; Liu JH; Yen CC; Chen WS; Jiang JK; Yang SH; Wang HS; Chen PM Hepatogastroenterology; 2004; 51(55):136-41. PubMed ID: 15011849 [TBL] [Abstract][Full Text] [Related]
20. [Sensitivity, specificity and prognostic value of CEA in colorectal cancer: results of a Tunisian series and literature review]. Bel Hadj Hmida Y; Tahri N; Sellami A; Yangui N; Jlidi R; Beyrouti MI; Krichen MS; Masmoudi H Tunis Med; 2001; 79(8-9):434-40. PubMed ID: 11774785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]